Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBunzl Regulatory News (BNZL)

Share Price Information for Bunzl (BNZL)

Share Price is delayed by 15 minutes
Get Live Data
2,390.00    108.00 (4.73%)
Bid:
2,380.00
Ask:
2,384.00
Spread: 4.00 (0.168%)
Market Cap: £7.67b
BNZL Live PriceLast checked at - London Stock Exchange

Intraday Bunzl Share Chart

Trading Statement

21 Dec 2022 07:00

RNS Number : 3732K
Bunzl PLC
21 December 2022
 

 

21 December 2022

 

BUNZL PRE-CLOSE STATEMENT

 

Bunzl plc, the specialist international distribution and services Group, is updating the market today prior to entering its closed period for the year ending 31 December 2022.

 

The Group is expected to deliver very strong growth over the year, continuing to reflect the resilience and strength of the Bunzl business model. Group revenue in 2022 is expected to increase year-on-year by approximately 17% at actual exchange rates and by approximately 10% at constant exchange rates, with inflation driving underlying revenue growth and the impact of acquisitions further supplementing growth1. Group adjusted operating margin is expected to be slightly ahead of prior guidance, in-line with that achieved in 2021 and above historic levels. Negotiations with our largest customer by revenue are ongoing.

 

Looking ahead, whilst we see continued uncertainties relating to the macroeconomic environment, at constant exchange rates the Group expects revenue in 2023 to be slightly higher than in 2022, driven by both organic growth and previously announced acquisitions, and partially offset by a small impact from a previously announced disposal. We expect Group adjusted operating profit in 2023 to be resilient, with operating margin slightly higher than historical levels. Adjusted earnings per share is expected to be moderately lower year-on-year due to higher interest rates and an increased effective tax rate.

 

Commenting on today's announcement, Frank van Zanten, Chief Executive Officer of Bunzl, said:

 

"Bunzl's performance over the year has continued to demonstrate the strength and resilience of the Bunzl business model. Our teams have successfully navigated the inflationary environment and supply chain disruption experienced this year to ensure customers have reliably received the essential products they need. Furthermore, we have continued to deliver on key strategic objectives, including supporting customers with innovative products that are better suited to a circular economy and have had our ambitious carbon emission reduction targets approved by the Science Based Targets initiative (SBTi). In addition, we have committed more than £280 million of spend to acquisitions over the year, with our pipeline remaining active and supported by our strong balance sheet."

 

 

 

Note:

1. The number of trading days will not have an impact on growth over the period. 

 

 

Enquiries:

Bunzl plc

Frank van Zanten, Chief Executive Officer

Richard Howes, Chief Financial Officer

Sunita Entwisle, Head of Investor Relations

Tel: +44 (0)20 7725 5000

Tulchan

Martin Robinson

Olivia Peters

Tel: +44 (0)20 7353 4200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBUBDDGUDDGDG
Date   Source Headline
30th Sep 20247:00 amRNSTransaction in Own Shares
27th Sep 20247:00 amRNSTransaction in Own Shares
26th Sep 20247:00 amRNSTransaction in Own Shares
25th Sep 20247:00 amRNSTransaction in Own Shares
24th Sep 20247:00 amRNSTransaction in Own Shares
23rd Sep 20247:00 amRNSTransaction in Own Shares
20th Sep 20247:00 amRNSTransaction in Own Shares
19th Sep 20247:00 amRNSTransaction in Own Shares
18th Sep 20247:00 amRNSTransaction in Own Shares
17th Sep 20242:31 pmRNSDirector/PDMR Shareholding
17th Sep 20247:00 amRNSTransaction in Own Shares
16th Sep 20247:00 amRNSTransaction in Own Shares
13th Sep 20247:00 amRNSTransaction in Own Shares
12th Sep 20247:00 amRNSTransaction in Own Shares
5th Sep 20249:50 amRNSDirector/PDMR Shareholding
5th Sep 20247:00 amRNSTransaction in Own Shares
4th Sep 20247:00 amRNSTransaction in Own Shares
3rd Sep 20247:00 amRNSTransaction in Own Shares
2nd Sep 202411:08 amRNSTotal Voting Rights
29th Aug 202412:55 pmRNSDirector/PDMR Shareholding
27th Aug 202410:00 amRNSDividend Declaration
27th Aug 20247:00 amRNSCommencement of Share Buyback Programme
27th Aug 20247:00 amRNSHalf-year Report
5th Aug 20244:45 pmRNSDirector/PDMR Shareholding
1st Aug 202411:50 amRNSTotal Voting Rights
26th Jul 20247:00 amRNSDirectorate Change
16th Jul 20249:45 amRNSDirector/PDMR Shareholding
15th Jul 20243:19 pmRNSDirector/PDMR Shareholding
11th Jul 202411:35 amRNSDirector/PDMR Shareholding
11th Jul 20247:00 amRNSAcquisition
4th Jul 20249:14 amRNSHolding(s) in Company
1st Jul 202411:43 amRNSTotal Voting Rights
28th Jun 20241:07 pmRNSDirector/PDMR Shareholding
27th Jun 20247:00 amRNSTrading Statement
24th Jun 202410:21 amRNSHolding(s) in Company
3rd Jun 202411:15 amRNSTotal Voting Rights
28th May 20247:00 amRNSAcquisition
23rd May 20248:00 amRNSAdditional Listing
22nd May 20242:30 pmRNSHolding(s) in Company
7th May 20243:35 pmRNSDirector/PDMR Shareholding
7th May 202411:40 amRNSDirector/PDMR Shareholding
2nd May 20242:00 pmRNSDirector/PDMR Shareholding
2nd May 20248:00 amRNSAdditional Listing
1st May 20245:00 pmRNSDirector/PDMR Shareholding
1st May 202410:00 amRNSBlock listing Interim Review
1st May 20249:18 amRNSTotal Voting Rights
25th Apr 20244:45 pmRNSDirector/PDMR Shareholding
24th Apr 20242:51 pmRNSResult of AGM
24th Apr 20247:00 amRNSTrading Statement
22nd Apr 20244:36 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.